Oracle and Certara are both IT and technology companies compared based on various factors. Oracle has higher revenues and earnings than Certara, but Certara trades at a lower price-to-earnings ratio, making it more affordable. Certara has a higher upside potential according to analyst recommendations. Institutional ownership is higher for Certara, indicating long-term outperformance. Oracle is less volatile compared to Certara in terms of stock price fluctuations. In summary, Oracle outperforms Certara on most factors compared. Oracle provides cloud software services while Certara offers biosimulation products and services for drug discovery and research.
Article Source
https://www.defenseworld.net/2024/07/02/head-to-head-survey-oracle-nyseorcl-certara-nasdaqcert.html
